Dennis M. Lanfear

Dennis M. Lanfear

President, Chief Executive Officer and Chairman of the Board of DirectorsatCoherus Oncology· In proxies 2021–2025

Pay in FY2025-43% from the year before · Coherus Oncology stock +2.9% the same year

Dennis M. Lanfear was paid $2.7M in FY2025 (Dec), down 43%. Coherus Oncology stock rose 2.9% that year.

Pay$100 in the stock at the end of FY20 → $8
Pay is from the Summary Compensation Table of each Coherus Oncology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Coherus OncologyPublic company · 5 yr
    • President, Chief Executive Officer and Chairman of the Board of Directors2021 – Present · 5 yrStock in role -93%
  2. Neuvogen, Inc.Public company · 6 yr
    • Director2019 – 2025 · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?